ALN-RSV01 is for treatment of RSV as opposed to preventing with a vaccine.Good catch. Is NVAX all alone in terms of developing a preventative vaccine for RSV? I can't imagine that being the case given the size of the potential market.
Market Data 
Markets 
AI
